|
ZNFX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.074200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.794100E-02 |
| Normal-vs-Stage2 |
2.529400E-01 |
| Normal-vs-Stage3 |
6.576800E-01 |
| Normal-vs-Stage4 |
5.784600E-01 |
| Stage1-vs-Stage2 |
1.037640E-02 |
| Stage1-vs-Stage3 |
1.919640E-02 |
| Stage1-vs-Stage4 |
3.097500E-02 |
| Stage2-vs-Stage3 |
4.158600E-01 |
| Stage2-vs-Stage4 |
5.690600E-01 |
| Stage3-vs-Stage4 |
8.660000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.968400E-01 |
| Normal-vs-AfricanAmerican |
4.682800E-01 |
| Normal-vs-Asian |
2.315600E-01 |
| Caucasian-vs-AfricanAmerican |
1.667370E-01 |
| Caucasian-vs-Asian |
4.221200E-01 |
| AfricanAmerican-vs-Asian |
2.575400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.594600E-01 |
| Normal-vs-Female |
2.475200E-01 |
| Male-vs-Female |
1.485810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.548000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.665200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.640000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.227800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.797200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.252400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.106200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.401600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.205600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.557800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.197900E-02 |
| Normal-vs-Grade 2 |
1.445640E-01 |
| Normal-vs-Grade 3 |
7.595800E-01 |
| Normal-vs-Grade 4 |
4.378800E-01 |
| Grade 1-vs-Grade 2 |
1.052450E-01 |
| Grade 1-vs-Grade 3 |
1.691910E-02 |
| Grade 1-vs-Grade 4 |
2.584200E-02 |
| Grade 2-vs-Grade 3 |
3.384200E-02 |
| Grade 2-vs-Grade 4 |
3.463600E-02 |
| Grade 3-vs-Grade 4 |
5.178600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.001700E-02 |
| Normal-vs-ccB subtype |
5.785600E-01 |
| ccA subtype-vs-ccB subtype |
1.064220E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.700000E-01 |
| Normal-vs-N1 |
7.693000E-01 |
| N0-vs-N1 |
8.252400E-01 |
|
|
